S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
His system isolated NVIDIA - Here's His Next Buy. (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
The single greatest medical breakthrough of all time? (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
His system isolated NVIDIA - Here's His Next Buy. (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
The single greatest medical breakthrough of all time? (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
His system isolated NVIDIA - Here's His Next Buy. (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
The single greatest medical breakthrough of all time? (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
His system isolated NVIDIA - Here's His Next Buy. (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
The single greatest medical breakthrough of all time? (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
OTCMKTS:MKGAF

Merck KGaA (MKGAF) Stock Forecast, Price & News

$166.00
+2.00 (+1.22%)
(As of 09/29/2023 ET)
Compare
Today's Range
$166.00
$168.28
50-Day Range
$162.06
$186.21
52-Week Range
$154.50
$219.04
Volume
193 shs
Average Volume
315 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

MKGAF stock logo

About Merck KGaA (OTCMKTS:MKGAF) Stock

Merck KGaA operates as a science and technology company in Germany. The company's Life Science segment offers a range of products, including reagents, consumable, devices, instruments, software, and services for scientific discovery, as well as provides lab water instruments, consumables and services, microbiology and biomonitoring, products, test assays, analytical reagents, and flow cytometry kits and instruments for pharma and biotech, industrial and testing, academics and government, and diagnostic sectors. Its Healthcare segment designs and develops medicines and intelligent devices for treatment of various therapeutics, such as oncology, neurology and immunology, endocrinology, and general medicines. The company's Electronic segment provides semiconductor solutions, such as semiconductor materials, delivery systems and services, and intermolecular services for semiconductor and polymer removal chemistries applications; and display solutions comprising liquid crystals, OLED and quantum materials, reactive mesogens, photoresist materials, smart antenna, and dynamic liquid crystal glazing products, as well as offers liviFlex, a flexible platform, which offers a range of display materials. This segment also provides surface solution, such as cosmetics, effect pigments, and functional solutions; architecture solutions, including switchable windows; and automotive solutions. In addition, it has strategic alliances with Pfizer Inc. and GlaxoSmihKline plc to develop and commercialize active ingredients in immune-oncology; in-licensing agreement with Debiopharm International SA for developing drug candidates for the treatment of head and neck cancer; and out-licensing agreement with MoonLake Immunotherapeutics AG for developing a drug candidate for the treatment of inflammatory diseases. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.

MKGAF Price History

MKGAF Stock News Headlines

AI Creates New Cancer Drug - In Just 30 Days!
On December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...
"Chilling War Games Show US Forces Crushed" – FOX NEWS
=== BREAKING === "Chilling War Games Show US Forces Crushed" - FOX NEWS After losing to China in repeated war games, U.S. military to spend billions on new "living missile" for armed forces. Investors stand to reap 35,960% on shares of small defense contractor that makes powerful new weapon. Get the name of the stock here >>>
MERCK KGAA DM 5 (OTC: MKGAF)
DGAP-DD: Merck KGaA english
Merck KGaA sees currencies supporting 2019 outlook
Merck KGaA agrees $6.5 bln takeover of Versum
See More Headlines
Receive MKGAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter.

MKGAF Company Calendar

Today
9/30/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:MKGAF
CIK
N/A
Employees
64,243
Year Founded
N/A

Profitability

Net Income
$3.50 billion
Pretax Margin
19.28%

Debt

Sales & Book Value

Annual Sales
$23.43 billion
Cash Flow
$52.87 per share
Book Value
$212.00 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.85
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Ms. Belen Garijo Lopez M.D. (Age 63)
    Chair of Exec. Board & CEO
    Comp: $6.31M
  • Ms. Helene von Roeder (Age 53)
    CFO & Member of Exec. Board
    Comp: $85.58k
  • Dr. Kai Beckmann (Age 58)
    CEO of Electronics & Member of the Exec. Board
    Comp: $4.82M
  • Mr. Peter Guenter (Age 61)
    CEO of Healthcare Bus. & Member of Exec. Board
    Comp: $5.56M
  • Dr. Matthias J. Heinzel (Age 56)
    CEO of Life Science Sector & Member of Exec. Board
    Comp: $4.34M
  • Mr. Constantin Fest (Age 46)
    Head of Investor Relations
  • Dr. Friederike Rotsch (Age 51)
    Group Gen. Counsel and Head of Group Legal & Compliance
  • Ms. Barbara Weiland (Age 49)
    Chief Compliance Officer
  • Mr. Dietmar Eidens (Age 65)
    Head of the Global HR Bus. Partner Organization
  • Mr. Frank Gotthardt
    Head of Corp. & Gov. Relations - Europe













MKGAF Stock - Frequently Asked Questions

How have MKGAF shares performed in 2023?

Merck KGaA's stock was trading at $195.00 at the beginning of 2023. Since then, MKGAF shares have decreased by 14.9% and is now trading at $166.00.
View the best growth stocks for 2023 here
.

What is Merck KGaA's stock symbol?

Merck KGaA trades on the OTCMKTS under the ticker symbol "MKGAF."

How do I buy shares of Merck KGaA?

Shares of MKGAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Merck KGaA's stock price today?

One share of MKGAF stock can currently be purchased for approximately $166.00.

How many employees does Merck KGaA have?

The company employs 64,243 workers across the globe.

How can I contact Merck KGaA?

Merck KGaA's mailing address is Frankfurter Strasse 250, Darmstadt 2M, 64293. The official website for the company is www.merckgroup.com. The company can be reached via phone at 496151720, via email at investor.relations@merck.de, or via fax at 49-61-5172-2000.

This page (OTCMKTS:MKGAF) was last updated on 9/30/2023 by MarketBeat.com Staff

My Account -